josamycin | CMAC

josamycin

Comparative Clinical and Microbiological Efficacy of 7-day and 10-day Courses of New Formulation of Josamycin in the Treatment of Acute Streptococcal Tonsillopharyngitis in Children and Adolescents

Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(3):241-254
This article presents data of multicenter open-label randomized clinical trial of clinical and microbiological efficacy and safety of 7- and 10-day courses of new formulation («Solutab») of josamycin in the treatment of acute streptococcal …

Efficacy and Safety of Josamycin in the Treatment of Mild-to-Moderate Community-Acquired Pneumonia: Results of Multicenter Clinical Study

Clinical Microbiology and Antimicrobial Chemotherapy. 2007; 9(1):48-56
Multicenter prospective non-comparative open-label clinical study to assess clinical and microbiological efficacy and safety of josamycin (16-memebered macrolide) in adults with non-severe community-acquired pneumonia (CAP) was performed. Patients …